Showing 104 of 104on this page. Filters & sort apply to loaded results; URL updates for sharing.104 of 104 on this page
Incyte wins Delaware Bio company of the year honor, again
MacroGenic Scores $900M Checkpoint PD-1 R&D Deal With Incyte - BioSpace
Incyte Canada Announces Health Canada approval of Opzelura ...
Incyte Corporation
Incyte inks trial collab with Calif. cancer firm - DBT
Incyte Wins Second Graft-Versus-Host Disease FDA Approval - BioSpace
Incyte Biosciences - Schiller & Wimmer Group
About Incyte Biosciences Canada | Biopharmaceutical Science
New Cancer Drug Data: Incyte Reveals Multiple Clinical Trial Results at ...
Incyte gets another graft-versus-host disease drug approval, this time ...
The Incyte Logo At The Entrance Of Incyte Corporation An American ...
Delaware’s Incyte moving HQ to Wilmington - WHYY
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can ...
Our Global Responsibility: By the Numbers | Incyte Stories
New Incyte bioplant opens in Switzerland - BioAlps
Incyte Leads S&P 500 Decliners on Skin Condition Drug Trial Results
Incyte wins accelerated approval for PD-1 in rare skin cancer
Canada. 17th May, 2025. In this photo illustration, the Incyte ...
Incyte Logo The Incyte Ingenuity Awards In GVHD™ And Vitiligo
Incyte Stories from Researchers and Scientists | Incyte.com
BM - Cytek(R）Muse(TM）Micro 5 channel: 細胞生物 - BIO
Incyte Announces Multiple Presentations, Including New Late-Breaking ...
Incyte – BioMarcommunications
Incyte opens new R&D lab in Wilmington - Delaware BioScience Association
Incyte Cholangiocarcinoma: Research and Perspectives
Incyte Announces New Positive Data for INCA033989, its First-In-Class ...
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the ...
Incyte buys its way into second blood cancer drug
Serving Patients Through Innovation | Incyte Stories
Incyte Higher on Plan to Develop Treatment for Myelofibrosis - TheStreet
Oncology Research | Targeted & Immuno-Therapy For Cancer | Incyte
Incyte announces agreement to acquire Escient Pharmaceuticals for $750m ...
About Incyte Biosciences Iberia | Biopharmaceutical Science
How Incyte Reached the 'Cutting Edge' of Cancer Research
Incyte buys into monoclonal antibody collab for $152M - DBT
Incyte expands into Wilmington, will double Delaware footprint
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific ...
Incyte logo hi-res stock photography and images - Alamy
L’azienda Usa Incyte sbarca in Italia - clipSALUTE
What are Mission Vision & Core Values of Incyte Company ...
Incyte gains FDA Breakthrough designation for its candidate against ...
Incyte Discontinues LIMBER-304 On Doubts Regarding Meeting Primary Goal ...
Incyte Gets Involved | Incyte Stories
Incyte Cancer Treatment Uses Patients' Immune System To Fight Disease ...
Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top ...
Los Angeles, USA - 1 February 2021: Incyte Corporation website page ...
Incyte Biosciences International Sàrl – Swiss Biotech
Thank You INCYTE | Skin of Color Update | Dermatology Conference | New ...
Incyte and Merck to collaborate on cancer drugs
Incyte Logo .PNG and .AI, .EPS, .CDR, .PDF, .SVG - iconLogoVector
Thank You to Incyte for Supporting Skin of Color Update 2021 | Skin of ...
Incyte - Viable Cell Density Monitoring, India
Incyte and Syndax Receives US FDA Approval for Niktimvo (axatilimab ...
Peluche sur mesure Incyte, société biopharmaceutique - Peluche Création
分子胶赛道“捷报连连”，默沙东、Incyte斥资深耕！_腾讯新闻
From A Small Team of Research Scientists, Chemists & Biologists ...
March 20 2023
Victory Capital Management Inc. Has $49.24 Million Stock Position in ...
Manufacturer Community - BSMA
Biomass Single-Use-Sensor
Global Biopharmaceutical Company | Incyte.com
The US FDA Approves Incyte’s Zynyz to Treat Adults with Squamous Cell ...
Patient Resources & Support | Incyte.com
Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical ...
Biopharmaceutical Company | Solutions for Unmet Medical Needs | Incyte.com
Incyte: Why This Biotech Beauty Can Stay Hot - Barron's
Incyte's cancer drug fails trial, a major blow for hopes for new treatment
Life Sciences | Select Greater Philadelphia
Incyte, a key player in Western Switzerland's biopharma landscape
Incyte’s cancer drug fails trial, marking major blow for immunotherapy ...
Single-Use bio-mass sensor
全球首款新药获批、单品种年销近28亿美元，Incyte到底是个怎样的药企？_药智新闻
HCP Medical Resources & Support | Incyte.com
Capacitance SUS Hamilton
AstraZeneca acquires startup for $2.4B: Delaware Money Moves
INCY Q2 Deep Dive: Product Launches and Pipeline Progress Underpin ...
医薬品開発＆科学的イノベーション | Incyte.jp
:max_bytes(150000):strip_icc()/GettyImages-2192875096-b3f1aec6b5974c43bf576307b14d1933.jpg)
